Aimmune Therapeutics, Inc. Business Finance Contracts & Agreements

21 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Aimmune Therapeutics, Inc. Underwriting Agreement with Merrill Lynch for 5,500,000 Shares of Common Stock
Underwriting Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2018
Aimmune Therapeutics, Inc. Common Stock Certificate (Specimen)
Stock Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2015
Aimmune Therapeutics, Inc. Common Stock Underwriting Agreement with Merrill Lynch and Credit Suisse (2015)
Underwriting Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2015
Aimmune Therapeutics, Inc. 2015 Equity Incentive Award Plan Global Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2020
Aimmune Therapeutics, Inc. 2015 Equity Incentive Award Plan Global Stock Option Grant Notice and Agreement
Warrant Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2020
Description of Registered Securities of Aimmune Therapeutics, Inc. under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Aimmune Therapeutics, Inc.
Biotechnology
2020
Securities Purchase Agreement between Aimmune Therapeutics, Inc. and Nestle Health Science US Holdings, Inc. dated February 4, 2020
Purchase Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2020
Amended and Restated Registration Rights Agreement between Aimmune Therapeutics, Inc. and Nestle Health Science US Holdings, Inc.
Registration Rights Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc
Purchase Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2019
Amended and Restated Registration Rights Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc
Registration Rights Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between Aimmune Therapeutics, Inc. and Nestle Health Science US Holdings, Inc. dated November 3, 2016
Purchase Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2017
Standstill Agreement between Nestle Health Science US Holdings, Inc. and Aimmune Therapeutics, Inc. (November 23, 2016)
Waiver Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2017
Registration Rights Agreement between Aimmune Therapeutics, Inc. and Nestle Health Science US Holdings, Inc. (November 23, 2016)
Registration Rights Agreements
Aimmune Therapeutics, Inc.
Biotechnology
NY
2017
Aimmune Therapeutics, Inc. 2015 Equity Incentive Award Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Aimmune Therapeutics, Inc.
Biotechnology
DE
2015
Aimmune Therapeutics, Inc. 2015 Equity Incentive Award Plan Stock Option Grant Notice and Agreement
Warrant Agreements
Aimmune Therapeutics, Inc.
Biotechnology
DE
2015
Aimmune Therapeutics, Inc. 2015 Equity Incentive Award Plan
Equity Distribution Agreements
Aimmune Therapeutics, Inc.
Biotechnology
DE
2015
Allergen Research Corporation Restricted Stock Grant and Agreement under 2013 Stock Plan
Stock Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2015
Allergen Research Corporation Immediately Exercisable Stock Option Grant and Agreement
Stock Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2015
Amendment to Allergen Research Corporation 2013 Stock Plan (Effective January 20, 2015)
Stock Agreements
Aimmune Therapeutics, Inc.
Biotechnology
2015
Allergen Research Corporation Amended and Restated 2013 Stock Plan
Stock Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2015
Amended and Restated Investors' Rights Agreement between Allergen Research Corporation and Investors (January 20, 2015)
Investor Rights Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2015